Clinical Trial Update: Comparison of High-Dose Rate Brachytherapy and Stereotactic Ablative Radiotherapy as Monotherapy for the Treatment of Localized Prostate Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial comparing high-dose-rate brachytherapy versus stereotactic ablative radiotherapy as monotherapy for localized prostate cancer; the study …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Snippet

Sponsor: Rutgers, The State University of New Jersey | Conditions: Stage I Prostate Cancer AJCC v8, Stage II Prostate Cancer AJCC v8 | Phase 2 | Status: ACTIVE_NOT_RECRUITING